Cogent BiosciencesCOGT
那斯達克 · USD
34.76
-0.19
(-0.54%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)
Cogent BiosciencesCOGT
34.76
-0.19
(-0.54%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 102,638 | 103,607 | 99,493 | 83,355 | 75,582 | - | - | - | - | - |
研發費用 | 70,811 | 75,365 | 75,559 | 68,989 | 62,203 | 63,029 | 62,045 | 63,614 | 54,294 | 52,705 |
推銷及管理費用 | 31,827 | 28,242 | 23,934 | 14,366 | 13,379 | 11,904 | 11,689 | 11,800 | 10,093 | 9,699 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -102,638 | -103,607 | -99,493 | -83,355 | -75,582 | -74,933 | -73,734 | -75,414 | -64,387 | -62,404 |
其他收入及費用 | 7,450 | 7,468 | -1,710 | 3,884 | 2,367 | 2,947 | 5,807 | 4,780 | 5,437 | 4,056 |
利息費用 | 1,217 | 1,213 | 1,289 | 1,459 | 314 | - | - | - | - | - |
稅前純益 | -96,405 | -97,352 | -102,492 | -80,930 | -73,529 | -71,986 | -67,927 | -70,634 | -58,950 | -58,348 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -96,405 | -97,352 | -102,492 | -80,930 | -73,529 | -71,986 | -67,927 | -70,634 | -58,950 | -58,348 |
基本每股稅後盈餘(元) | -0.52 | -0.57 | -0.30 | -0.58 | -0.65 | -0.63 | -0.61 | -0.52 | -0.43 | -0.49 |
稀釋每股稅後盈餘(元) | -0.52 | -0.53 | -0.61 | -0.50 | -0.53 | -0.52 | -0.50 | -0.53 | -0.42 | -0.49 |
基本平均股數(千股) | 171005.00 | 170773.00 | 147986.00 | 139827.00 | 113928.00 | 113856.00 | 110461.00 | 110165.00 | 99240.00 | 94804.00 |
稀釋平均股數(千股) | 171005.00 | 170773.00 | 147986.00 | 139827.00 | 113928.00 | 113856.00 | 110461.00 | 110165.00 | 99240.00 | 94804.00 |
還原基本每股稅後盈餘(元) | -0.52 | -0.57 | -0.30 | -0.58 | -0.65 | -0.63 | -0.61 | -0.52 | -0.43 | -0.49 |
還原稀釋每股稅後盈餘(元) | -0.52 | -0.53 | -0.61 | -0.50 | -0.53 | -0.52 | -0.50 | -0.53 | -0.42 | -0.49 |
還原基本平均股數(千股) | 171,005 | 170,773 | 147,986 | 139,827 | 113,928 | 113,856 | 110,461 | 110,165 | 99,240 | 94,804 |
還原稀釋平均股數(千股) | 171,005 | 170,773 | 147,986 | 139,827 | 113,928 | 113,856 | 110,461 | 110,165 | 99,240 | 94,804 |
EBITDA(千元) | -94,496 | -95,886 | -100,880 | -78,191 | -71,779 | -71,803 | -69,423 | -75,737 | -55,289 | -58,678 |